000			02392nam a2200121Ia 4500
008			220616s9999||||xx |||||||||||||| ||und||
100			_aBrüssow, Harald
245		0	_aHurdles for Phage Therapy (PT) to Become a Reality
546			_aEnglish[eng]
650			_aalginate||abortive infection||n/a||bacterial resistance||bacteriophages||ATMP||MALDI-MS||adaptation||Bacteriophage||horizontal gene transfer||adaptive immunity||co-evolution||Listeria ivanovii||personalised medicines||pH stability||phage-human host interaction||vB_SauM-fRuSau02||antimicrobial resistance||phagodisinfection||biofilm||capsule depolymerase||animal model||phage cocktails||Enterococcus||cases report||zoonosis||resistance||magistral formula||experimental therapy||Belgium||phage therapy||E. faecalis||nontraditional antibacterial||industrial phage application||Democratic Republic of the Congo||OrthoMCL||Germany||high-throughput sequencing||antimicrobial||infection||antibiotic therapy||Kayvirus||phages||Twortlikevirus||bacterial disease||human host||Pseudomonas aeruginosa||phage||multidrug-resistant bacteria||bacterial infection||Salmonella Typhi||rhamnopolysaccharide||compassionate use||crop production||compounding pharmacy||antimicrobial resistance (AMR)||best practices||bacteriophage efficacy||phage sensitivity||antibiotic-resistance||antibiotic||lysins||PTMP||Escherichia coli||typhoid fever||patent landscape||phage preparation||innate immunity||anti-phage antibodies||immunology||Staphylococcus aureus||global health||clinical trial||adsorption||Brussels||phage-resistance||Galleria mellonella||science communication||history of science||virus–host interactions||foodborne illness||prophage||resistance management||biofilms||IND||immunomodulation||frequency of resistance||capsule||gastrointestinal tract||phage-host interactions||disinfection||production||bacteriophage therapy||bacteriophage||Staphylococcus||magistral preparation||extended-spectrum beta lactamases (ESBL)||Viral proteins||antibiotic resistance||genomics||phage biocontrol||therapy||target selection||viral genomes||evolution||pharmaceutical paradigm shift||personalized medicine||pharmaceutical legislation||food safety||regulation||virulence||developing countries||infectious disease||regulatory framework||sustainable agriculture||Klebsiella pneumoniae
856			_uhttps://mdpi.com/books/pdfview/book/1504
942			_cEB
999			_c20137 _d20137